Home > News > Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
February 11th, 2004
Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
With nanobiotech research growing at an astounding rate - and funds starting to follow - what are the most promising near-term prospects for nanomedicine? Predicting which applications will have the resources - and luck - to succeed is a dicey proposition, experts acknowledge. But NanoBiotech News posed the questions to the field's preeminent pioneers and found that real-world applications of nanomedicine will happen within five years. Ground-breaking nanotechnology researcher Ralph C. Merkle, Ph.D., and the father of nanomedicine Robert A. Freitas, Jr., JD, are among the industry heavyweights who weighed in with NanoBiotech News on the state of the science and where it's headed.
Malvern specialist to explore use of Nanoparticle Tracking Analysis for characterizing extracellular vesicles at ISEV 2014 March 11th, 2014
Arrowhead to Present at Barclays Global Healthcare Conference March 11th, 2014
Production of Bioactive Material for Quick Treatment of Bone Damages March 10th, 2014
Production of New Type of Electrochemical Drug Sensors for Cardiovascular Diseases March 10th, 2014